Chemical.AI, a global leader in AI for chemical R&D, recently announced collaboration with Aragen Life Sciences (Aragen), a leading Contract Research Development and Manufacturing Organization (CRDMO) headquartered in India, to accelerate Aragen’s drug research and development with ChemAIRS, an AI-powered retrosynthesis routes design platform.

As part of the collaboration, ChemAIRS will be locally deployed on Aragen’s servers to ensure faster process and greater data confidentiality, integrity and availability.

“We’re excited to drive innovation in the pharmaceutical industry with Aragen,” said Dr. Ning Xia, CEO of Chemical.AI. “Retrosynthetic approach plays a key part in the success of drug discovery, which is very challenging with versatile combinations of reagents, catalysts and techniques. By seamlessly integrating AI with chemistry experiences and data, Chemical.AI is determined to provide faster and more efficient route design, condition optimization, and beyond.”

With Chemical.AI’s proprietary deep learning algorithm and ever-growing chemical dataset, ChemAIRS provides state-of-art retrosynthetic planning, fully considering key factors including reaction feasibility, functional group compatibility, chiral synthesis strategies, and many more. Once the target molecule is provided, ChemAIRS exhausts all plausible synthetic routes within minutes and proposes various design ideas. Scientists can either choose a feasible path supported by academic literatures or adjust intermediates and conditions manually.

About Aragen

Aragen Life Sciences is a leading R&D and manufacturing solutions provider to the global life sciences industries. Aragen offers a range of solutions across the drug development continuum to advance small and large molecule programs. With more than 20 years of experience, the Company operates through a global network of six sites with a team of 4200+ employees and 450+ PhDs. Its expertise and experience have enabled over 450 customers (including 7 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen's innovative mindset, infrastructure, flexible business models, a clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.

About Chemical.AI

Founded in 2018, Chemical.AI leads the innovation in chemical synthesis through AI and automation. We work with over 100 companies and research institutes to enhance chemical synthesis strategies, processes, and productivity by integrating proprietary retrosynthesis algorithms, comprehensive chemical data, and state-of-the-art robotic lab automation. Our goal is to provide advanced cheminformatics and automated solutions across diverse sectors such as pharmaceuticals, materials, biomedicine, and chemical engineering.

Contact: pr@chemical.ai